Physician profile
Alexander Kushnir
NPI 1417218488
$27,320.88
in general payments reported to CMS, 2019-2025
14 companies · $2,022 in 2025
The $2,022 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $8,064 · 2021: $540 · 2022: $573 · 2023: $1,385 · 2024: $2,141 · 2025: $2,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,888 · Food and Beverage: $1,860 · Consulting Fee: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,887.90 |
| Food and Beverage | $1,859.61 |
| Consulting Fee | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $13,036.09 | 2019-2020 | |
| Boston Scientific Corporation | $7,294.26 | 2019-2025 | General - Therapies, General - Ep, Farapulse |
| Abbott Laboratories | $2,495.02 | 2019-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet |
| Medtronic, INC. | $1,780.12 | 2021-2025 | Evera Mri Xt Dr Surescan, Azure Xt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Biotronik INC. | $1,245.39 | 2022-2024 | |
| Biosense Webster, INC. | $907.75 | 2023-2025 | Carto 3, Qdot Micro Catheter |
| Abiomed | $192.83 | 2021 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2021 | |
| Altathera Pharmaceuticals LLC | $68.10 | 2025 | Sotalol Hydrochloride |
| Kestra Medical Technology Services, INC. | $57.80 | 2022-2025 | Assure Wcd |
| Cardiva Medical, INC. | $45.56 | 2022 | |
| Philips North America LLC | $28.13 | 2025 | Igt Devices Undivided |
| Pfizer INC. | $23.15 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $21.68 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Kushnir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.